These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26603157)
1. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer. Yun SP; Seo HI BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157 [TBL] [Abstract][Full Text] [Related]
2. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas. Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509 [TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival. Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma. Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202 [TBL] [Abstract][Full Text] [Related]
6. Clinical impact of ampulla of Vater cancer subtype classification based on immunohistochemical staining. Kwon CH; Ahn JH; Seo HI; Kim DU; Han SY; Kim S; Lee NK; Hong SB; Park YM; Noh BG World J Surg Oncol; 2024 Jan; 22(1):5. PubMed ID: 38167037 [TBL] [Abstract][Full Text] [Related]
7. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance]. Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858 [No Abstract] [Full Text] [Related]
8. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater. Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104 [TBL] [Abstract][Full Text] [Related]
9. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer. Luo HT; Liang CX; Luo RC; Gu WG Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446 [TBL] [Abstract][Full Text] [Related]
10. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis. Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683 [TBL] [Abstract][Full Text] [Related]
11. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins. Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085 [TBL] [Abstract][Full Text] [Related]
12. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater. de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918 [TBL] [Abstract][Full Text] [Related]
13. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin. Zhao XQ; Dong JH; Zhang WZ; Liu Z Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455 [TBL] [Abstract][Full Text] [Related]
14. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma. Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853 [TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Zhou H; Schaefer N; Wolff M; Fischer HP Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956 [TBL] [Abstract][Full Text] [Related]
16. [Cytokeratins 7 and 20 immunohistochemistry in ampullary carcinomas]. Le Pessot F; Ranty ML; Hellot MF; Lemoine F; Ténière P; Testart J; Métayer J Ann Pathol; 2004 Sep; 24(4):312-8. PubMed ID: 15567946 [TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes and prognostic factors for ampulla of Vater cancer. Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384 [TBL] [Abstract][Full Text] [Related]
18. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774 [TBL] [Abstract][Full Text] [Related]
19. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma. Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater. da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]